Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Curevac N.V. buy MoneyMoney

Start price
€40.50
27.11.21 / 0%
Target price
€17.00
27.11.22
Performance (%)
-81.97%
End price
€7.30
28.11.22
Summary
This prediction ended on 28.11.22 with a price of €7.30. The BUY prediction by MoneyMoney for Curevac N.V. performed very badly with a performance of -81.97%. MoneyMoney has a follow-up prediction for Curevac N.V. where he still thinks Curevac N.V. is a Buy. This prediction was marked as speculative and is excluded from MoneyMoney's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Curevac N.V. 5.450% 5.450% -
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

According to MoneyMoney what are the pros and cons of Curevac N.V. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Future proof or reliable business model
Revenue growth > 30% per year expected
High Investments for future growth
Stable Large shareholder and/or long term investor
Some uniques
EBIT growth > 30% per year expected
positive Cash Flow expected
Innovative
Market Leader or Top 3
Known brand
Capable Management
Good rating
Good culture
Cons
Increased challenges to pay loans and raise capital
Lower EBIT Margin than peer group
Higher risks for its business
Low dividend yield expected
Significant cyclical dependencies
Dependend from some customers or products
High valuation
Risky balance sheet
Growths slower than the competition

Comments by MoneyMoney for this prediction

In the thread Curevac N.V. diskutieren
Prediction Buy
Perf. (%) -81.97%
Target price 50.000
Change
Ends at 27.11.22

Buy mit Kursziel 50,0

Prediction Buy
Perf. (%) -81.97%
Target price 40.000
Change
Ends at 27.11.22

Kursziel geändert auf 40,0

Prediction Buy
Perf. (%) -81.97%
Target price 22.000
Change
Ends at 27.11.22

Kursziel geändert auf 22,0

Prediction Buy
Perf. (%) -81.97%
Target price 25.000
Change
Ends at 27.11.22

Kursziel geändert auf 25,0

Prediction Buy
Perf. (%) -81.97%
Target price 22.000
Change
Ends at 27.11.22

Kursziel geändert auf 22,0

Prediction Buy
Perf. (%) -81.97%
Target price 20.000
Change
Ends at 27.11.22

Kursziel geändert auf 20,0

Prediction Buy
Perf. (%) -81.97%
Target price 25.000
Change
Ends at 27.11.22

Kursziel geändert auf 25,0

Prediction Buy
Perf. (%) -81.97%
Target price 17.000
Change
Ends at 27.11.22

Kursziel geändert auf 17,0

In the thread Trading Curevac N.v.
Prediction Buy
Perf. (%) -81.97%
Target price 17.000
Change
Ends at 27.11.22

Die von MoneyMoney gewählte maximale Laufzeit wurde überschritten

Current prediction by MoneyMoney for Curevac N.V.

buy
Curevac N.V.

Start price
Target price
Perf. (%)
€5.11
10.12.23
€8.00
10.12.24
-45.30%
09:50

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Future proof or reliable business model
Increased challenges to pay loans and raise capital

Stopped prediction by MoneyMoney for Curevac N.V.

buy
Curevac N.V.

Start price
Target price
Perf. (%)
€42.80
21.09.20
€50.00
04.11.21
-16.45%
05.11.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Future proof or reliable business model
Increased challenges to pay loans and raise capital